About us

OMIX SCIENCE is an AI-driven medical company founded by a team of Harvard Ph.D. graduates. The company integrates world-leading technologies across artificial intelligence (AI), synthetic biotechnology (BT), medical technology (MT), and information technology (IT), focusing on two strategic areas: early detection of complex diseases and aging intervention.

Leveraging internationally competitive R&D capabilities, the company is deeply engaged across three golden sectors: biopharmaceuticals, information technology, and the silver economy. Committed to spearheading industry transformation, the company is building a globally influential innovation cluster centered on "AI + Early Disease Detection + Aging and Aging-Related Diseases Intervention", establishing a new paradigm of synergistic industrial development.